Scarica l'app Stockscreener
2.76
0.72%
-0.02
Mereo Biopharma Group Plc Adr Borsa (MREO) Ultime notizie
SEC Form N-CSRS filed by abrdn World Healthcare Fund Shares of Beneficial Interest - Quantisnow
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), ACADIA Pharmaceuticals (ACAD) and Quanterix (QTRX) - The Globe and Mail
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Stock Sentiment: What’s Wall Street Saying? - Stocksregister
Analysts Offer Insights on Healthcare Companies: Organon (OGN), Diamedica Therapeutics (DMAC) and Nkarta (NKTX) - The Globe and Mail
Mereo BioPharma Group plc SEC 10-Q Report - TradingView
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights - GlobeNewswire
Mereo Biopharma Group Plc ADR (MREO) can make a big difference with a little luck - Sete News
Analyzing Mereo Biopharma Group Plc ADR (MREO) After Recent Trading Activity - knoxdaily.com
How should investors view Mereo Biopharma Group Plc ADR (MREO)? - uspostnews.com
Analytical Overview: Mereo Biopharma Group Plc ADR (MREO)’s Ratios Tell a Financial Story - DWinneX
Balance Sheet Insights: Halliburton Co (HAL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
INN’s latest rating updates from top analysts. - knoxdaily.com
EVLV’s 2023 Market Dance: Down -10.63% – Time to Invest? - investchronicle.com
Mereo Biopharma Group Plc ADR: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com
Mereo Biopharma Group Plc ADR [MREO] Shares Fall -0.78 % on Thursday - knoxdaily.com
Brookdale Senior Living Inc [BKD] Records 50-Day SMA of $5.84 - knoxdaily.com
VST Stock Sees Surge of Approximately 7.21% in Last Five Days - knoxdaily.com
Core & Main Inc [NYSE: CNM] Sees Increase in Stock Value - knoxdaily.com
This trade activity should not be overlooked: Mereo Biopharma Group Plc ADR (MREO) - Sete News
Financial Metrics Check: B. Riley Financial Inc (RILY)’s Ratios for Trailing Twelve Months - DWinneX
Mereo Biopharma Group Plc ADR [MREO] Investment Appeal on the Rise - knoxdaily.com
Freeport-McMoRan Inc [FCX] Stock sold by Insider Robertson Maree E. for $0.58 million - knoxdaily.com
D.R. Horton Inc (DHI) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Insider Sale Alert: Genworth Financial Inc [GNW] – Is it Time to sell? - knoxdaily.com
Mereo Biopharma Group Plc ADR (MREO) requires closer examination - uspostnews.com
SMX (Security Matters) Plc (SMX) shows promising results - uspostnews.com
Should investors be concerned about Uranium Energy Corp (UEC)? - uspostnews.com
Is Aquestive Therapeutics Inc (AQST) worth investing in despite its overvalued state? - uspostnews.com
Are Dave & Buster’s Entertainment Inc (PLAY) shares a good deal now? - uspostnews.com
EOLS Stock Sees Decline of Approximately -17.34% in Last Five Days - knoxdaily.com
There is no way Allarity Therapeutics Inc (ALLR) can keep these numbers up - Sete News
Mereo BioPharma stock hits 52-week low at $2.1 amid market challenges By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.1 amid market challenges - Investing.com India
C3is Inc Inc. (CISS) Price Performance Over the Years: A Comparative Study - investchronicle.com
Microchip Technology, Inc [MCHP] Stock sold by Insider Bjornholt James Eric for $0.23 million - knoxdaily.com
Mereo BioPharma’s SWOT analysis: rare disease stock poised for breakthrough - Investing.com India
Mereo BioPharma’s SWOT analysis: rare disease stock poised for breakthrough By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.25 - Investing.com India
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights - GlobeNewswire
Mereo BioPharma Secures 3-Year Cash Runway While Pushing Phase 3 Studies Forward - Stock Titan
Closing Bell Recap: WANG & LEE Group Inc (WLGS) Ends at 0.43, Reflecting a -42.70 Downturn - The Dwinnex
Pfizer to Exit Sensodyne-Maker Haleon With Final Stake Sale - MSN
MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock? - MSN
ARS Pharmaceuticals outlines 2025 growth strategy with neffy commercialization and global expansion - MSN
Mereo BioPharma’s SWOT analysis: setrusumab, alvelestat drive rare disease stock potential - Investing.com India
Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - Barchart
How Do Things Look For Mereo Biopharma Group Plc ADR (NASDAQ: MREO) In The Short-Term? - Stocks Register
Mereo BioPharma stock hits 52-week low at $2.52 By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.52 - Investing.com India
Prepare Yourself for Liftoff: Mereo Biopharma Group Plc ADR (MREO) - SETE News
There is no doubt that OrganiGram Holdings Inc (OGI) ticks all the boxes. - SETE News
Check Out ImmunoPrecise Antibodies Ltd (IPA)’s Trade Data Rather Than the Analysts’ Views - SETE News
Recent Insider Activity Could Benefit Mereo Biopharma Group Plc ADR (MREO) - Knox Daily
Analyzing Digital Turbine Inc (APPS) After Recent Trading Activity - Knox Daily
Market Insights: Mereo Biopharma Group Plc ADR (MREO)’s Notable Drop of -0.66, Closing at 2.99 - The Dwinnex
Daily Market Movement: Twist Bioscience Corp (TWST) Sees a 0.73 Increase, Closing at 52.75 - The Dwinnex
In the Green: Sensata Technologies Holding Plc (ST) Closes at 25.62, Up/Down -5.67 from Previous Day - The Dwinnex
How should investors view Anavex Life Sciences Corporation (AVXL)? - US Post News
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):